'Biosimilars market dynamics' presentation slideshows

Indonesia generated the highest revenue in the ASEAN biosimilars market in 2017 and is expected to remain dominant throughout the forecast period. Based on molecule type, the erythropoietin segment accounted for the second highest share in the ASEAN and China biosimilars market in 2017 and is expected to maintain this trend throughout the forecast period. Based on application, the blood disorders segment is estimated to rank second in terms of revenue in both, the ASEAN, and the China biosimilars market throughout the analysis period. The diabetes segment generated the highest CAGR from 2018 to 2025 in the ASEAN and China biosimilars market.

88 views • 8 slides

Biosimilars Market Necessity And Demand 2018 to 2026

Biosimilars are biopharmaceutical drug having active components, which are similar to one that has previously been licensed.

39 views • 3 slides

Biosimilars Market Trends, Outlook, and Opportunity Analysis, 2018-2026

Biosimilars are biopharmaceutical drugs that have active components and are similar to the drugs, which have been previously licensed.

39 views • 3 slides